Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > Iron Nanoparticle Tools Could Detect Pancreatic Cancer Earlier

Abstract:
Pancreatic cancer has a devastatingly low survival rate (less than five percent after five years) because it is usually diagnosed at an advanced stage. The initial symptoms, such as pain, jaundice or weight loss, often do not allow the disease to be caught early enough for surgery and chemotherapy to be effective.

Iron Nanoparticle Tools Could Detect Pancreatic Cancer Earlier

Atlanta, GA | Posted on May 6th, 2009

Emory researchers have created tools for early diagnosis of pancreatic cancer by attaching a molecule that binds specifically to pancreatic cancer cells to tiny "nanoparticles" made of iron oxide.

The iron makes the particles clearly visible under magnetic resonance imaging (MRI). Tested in mice with implanted human tumors, the particles can also be seen by scanning the mice with a specialized camera because the particles are studded with near infrared dyes.

The nanoparticles' properties are described in the May issue of the journal Gastroenterology.

The research was a collaboration between Lily Yang, MD, associate professor of surgery at Emory University School of Medicine, Hui Mao, PhD, associate professor of radiology at Emory, and Shuming Nie, PhD, a professor in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University.

Additional contributions came from Charles Staley, MD, and William Wood, MD, both professors of surgery at Emory School of Medicine, and from Y. Andrew Wang of Ocean Nanotech LLC.

"This work is an early demonstration that nanoparticles can be developed to target pancreatic cancer, opening new opportunities in detecting and treating tumors of low survival rates," says Nie,

"We believe these nanoparticles could be useful tools for detection and localization before surgery, detection of tumor margins and metastases during surgery, and monitoring the response to therapy," Yang says. "We are working on multifunctional nanoparticles that could both detect pancreatic tumors by molecular imaging and deliver therapeutic agents in a targeted fashion."

The iron oxide particles have a core that is 10 nanometers in diameter, with a polymer coating. The molecule that allows the particles to discriminate between pancreatic cancer cells and healthy cells is an engineered small protein based on a natural protein found in humans, urokinase plasminogen activator (uPA), which binds to its receptor (uPAR) on cancer cells.

The authors note that uPA is useful in discriminating tumor cells from regular pancreas cells irritated by chronic pancreatitis, a challenging task in clinical diagnosis.

Particles coated with a fragment of uPA are taken up by pancreatic cancer cells and not by normal pancreatic tissues, they found. Tumor endothelial cells, which line blood vessels, also take up the particles, and a low signal is seen in liver and spleen.

Tumors as small as one millimeter across can be detected by MRI or optical imaging. The technology now needs to be refined so that it is ready to test in patients. Groups of patients that are at increased risk of pancreatic cancer, such as those with inherited cancer risk factors, chronic pancreatitis or new-onset diabetes, could benefit.

Reference:
Yang, L. et al Molecular Imaging of Pancreatic Cancer in an Animal Model Using Targeted Multifunctional Nanoparticles. Gastroenterology 136, 1514-1525 (May 2009)

####

About Emory University
The Robert W. Woodruff Health Sciences Center of Emory University is an academic health science and service center focused on missions of teaching, research, health care and public service. Its components include the Emory University School of Medicine, Nell Hodgson Woodruff School of Nursing, and Rollins School of Public Health; Yerkes National Primate Research Center; Emory Winship Cancer Institute; and Emory Healthcare, the largest, most comprehensive health system in Georgia. Emory Healthcare includes: The Emory Clinic, Emory-Children's Center, Emory University Hospital, Emory University Hospital Midtown, Wesley Woods Center, Emory University Orthopaedics & Spine Hospital, the jointly owned Emory-Adventist Hospital, and EHCA, a limited liability company created with Hospital Corporation of America. EHCA includes two joint venture hospitals, Emory Eastside Medical Center and Emory Johns Creek Hospital. The Woodruff Health Sciences Center has a $2.3 billion budget, 18,000 employees, 2,500 full-time and 1,500 affiliated faculty, 4,300 students and trainees, and a $5.5 billion economic impact on metro Atlanta.

For more information, please click here

Contacts:
Holly Korschun
404-727-3990

Copyright © Emory University

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

'Exotic' material is like a switch when super thin April 18th, 2014

Innovative strategy to facilitate organ repair April 18th, 2014

Oxford Instruments Asylum Research Introduces the MFP-3D InfinityTM AFM Featuring Powerful New Capabilities and Stunning High Performance April 18th, 2014

Conductive Inks: booming to $2.8 billion by 2024 April 17th, 2014

Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Champions Oncology, Inc. April 17th, 2014

Imaging

Oxford Instruments Asylum Research Introduces the MFP-3D InfinityTM AFM Featuring Powerful New Capabilities and Stunning High Performance April 18th, 2014

More effective kidney stone treatment, from the macroscopic to the nanoscale April 17th, 2014

Nanomedicine

Innovative strategy to facilitate organ repair April 18th, 2014

Novel stapled peptide nanoparticle combination prevents RSV infection, study finds April 17th, 2014

More effective kidney stone treatment, from the macroscopic to the nanoscale April 17th, 2014

High-temperature plasmonics eyed for solar, computer innovation April 17th, 2014

Discoveries

'Exotic' material is like a switch when super thin April 18th, 2014

Innovative strategy to facilitate organ repair April 18th, 2014

Thinnest feasible membrane produced April 17th, 2014

More effective kidney stone treatment, from the macroscopic to the nanoscale April 17th, 2014

Announcements

'Exotic' material is like a switch when super thin April 18th, 2014

Innovative strategy to facilitate organ repair April 18th, 2014

Oxford Instruments Asylum Research Introduces the MFP-3D InfinityTM AFM Featuring Powerful New Capabilities and Stunning High Performance April 18th, 2014

Transparent Conductive Films and Sensors Are Hot Segments in Printed Electronics: Start-ups in these fields show above-average momentum, while companies working on emissive displays such as OLED are fading, Lux Research says April 17th, 2014

NanoNews-Digest
The latest news from around the world, FREE







  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE